$2.10
6.25% today
Nasdaq, Sep 16, 04:42 pm CET
ISIN
US68373L2088
Symbol
OPGN
Sector
Industry

OpGen, Inc. Stock price

$2.24
+0.14 6.67% 1M
-2.96 56.93% 6M
-1.96 46.67% YTD
+0.03 1.36% 1Y
-597.76 99.63% 3Y
-1,597.76 99.86% 5Y
-484,997.76 100.00% 10Y
Nasdaq, Closing price Fri, Sep 13 2024
+0.16 7.69%
ISIN
US68373L2088
Symbol
OPGN
Sector
Industry

Key metrics

Market capitalization $18.72m
Enterprise Value $32.03m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 16.34
P/S ratio (TTM) P/S ratio 9.55
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth -30.32%
Revenue (TTM) Revenue $1.96m
EBIT (operating result TTM) EBIT $-8.75m
Free Cash Flow (TTM) Free Cash Flow $-6.51m
Cash position $170.00k
EPS (TTM) EPS $-18.94
Short interest 1.79%
Show more

Is OpGen, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.

OpGen, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast OpGen, Inc.:

1x Hold
100%

Analyst Opinions

1 Analyst has issued a forecast OpGen, Inc.:

Hold
100%

Financial data from OpGen, Inc.

Jun '24
+/-
%
Net Profit -22 -22
38% 38%
-1,142%
Depreciation and Amortization 0.68 0.68
51% 51%
35%
Stock Compensation 0.42 0.42
49% 49%
21%
Operating Cash Flow -6.41 -6.41
65% 65%
-327%
Investments 0.10 0.10
92% 92%
5%
Dividend Paid - -
-
-
Free Cash Flow -6.51 -6.51
67% 67%
-332%

In millions USD.

Don't miss a Thing! We will send you all news about OpGen, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OpGen, Inc. Stock News

Neutral
InvestorPlace
26 days ago
OpGen (NASDAQ: OPGN ) just reported results for the second quarter of 2024. OpGen reported earnings per share of -$1.18.
Neutral
InvestorPlace
3 months ago
OpGen (NASDAQ: OPGN ) just reported results for the fourth quarter of 2023. OpGen reported earnings per share of -$17.67.
Neutral
GlobeNewsWire
4 months ago
ROCKVILLE, Md., May 24, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”) announced today that it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) due to the Company not filing its Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Form 10-Q”), whic...
More OpGen, Inc. News

Company Profile

OpGen, Inc. engages in the development of molecular information products and services for global healthcare settings. It offers guidance to clinicians about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.

Head office United States
CEO Hon Tan
Founded 2001
Website www.opgen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today